Process View
The invasion by an organism of a cell of its host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "entry into host cell"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.983 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.981 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.925 | ||
| TRIM39 | tripartite motif containing 39 | 0.723 | Human | |
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.599 | ||
| PVRL4 | poliovirus receptor-related 4 | 0.401 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.390 | ||
| TRIM43 | tripartite motif containing 43 | 0.374 | ||
| FHL2 | four and a half LIM domains 2 | 0.337 | ||
| MED15 | mediator complex subunit 15 | 0.335 | ||
| TLN1 | talin 1 | 0.304 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.294 | ||
| UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | 0.271 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.261 | ||
| ENG | endoglin | 0.259 | ||
| AXL | AXL receptor tyrosine kinase | 0.250 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.179 | ||
| ITGB4 | integrin, beta 4 | 0.164 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.137 | ||
| TRIM21 | tripartite motif containing 21 | 0.116 | Human Mouse | |
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.102 | ||
| TRIM41 | tripartite motif containing 41 | 0.101 | Human | |
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.100 | ||
| STX7 | syntaxin 7 | 0.095 | ||
| TRIM5 | tripartite motif containing 5 | 0.090 | ||
| GCC1 | GRIP and coiled-coil domain containing 1 | 0.089 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.081 | ||
| THBS1 | thrombospondin 1 | 0.080 | ||
| RNF5 | ring finger protein 5 | 0.072 | ||
| FN1 | fibronectin 1 | 0.068 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.066 | Human | |
| TRIM26 | tripartite motif containing 26 | 0.061 | ||
| ZNF263 | zinc finger protein 263 | 0.059 | ||
| UBE2U | ubiquitin-conjugating enzyme E2U (putative) | 0.057 | ||
| PML | promyelocytic leukemia | 0.049 | ||
| MAGEA4 | melanoma antigen family A, 4 | 0.049 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.045 | ||
| CD63 | CD63 molecule | 0.044 | ||
| EFCAB4B | EF-hand calcium binding domain 4B | 0.044 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.039 | ||
| ARIH2 | ariadne homolog 2 (Drosophila) | 0.038 | ||
| TRIM32 | tripartite motif containing 32 | 0.037 | ||
| IRF9 | interferon regulatory factor 9 | 0.036 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.034 | ||
| ZNRF1 | zinc and ring finger 1 | 0.034 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.033 | Human | |
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.031 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.030 | ||
| TRIM8 | tripartite motif containing 8 | 0.029 | Mouse | |
| HLA-A | major histocompatibility complex, class I, A | 0.029 | ||
| LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.028 | ||
| ZNF473 | zinc finger protein 473 | 0.026 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.025 | ||
| DYDC1 | DPY30 domain containing 1 | 0.025 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.024 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.024 | ||
| B2M | beta-2-microglobulin | 0.024 | ||
| ITGB5 | integrin, beta 5 | 0.023 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.023 | ||
| RNF126 | ring finger protein 126 | 0.022 | ||
| TRIM17 | tripartite motif containing 17 | 0.021 | Human | |
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.021 | ||
| TRIM34 | tripartite motif containing 34 | 0.021 | ||
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.021 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.020 | ||
| RNF185 | ring finger protein 185 | 0.020 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.020 | ||
| RNF181 | ring finger protein 181 | 0.019 | ||
| MKRN3 | makorin ring finger protein 3 | 0.019 | ||
| IFNA16 | interferon, alpha 16 | 0.017 | Human | |
| RNF32 | ring finger protein 32 | 0.017 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.016 | ||
| SP110 | SP110 nuclear body protein | 0.016 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.016 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.016 | Human | |
| RNF10 | ring finger protein 10 | 0.016 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.015 | ||
| PXN | paxillin | 0.015 | ||
| C19orf66 | chromosome 19 open reading frame 66 | 0.015 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.015 | ||
| PDLIM5 | PDZ and LIM domain 5 | 0.015 | ||
| ANXA1 | annexin A1 | 0.014 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.014 | ||
| RNF2 | ring finger protein 2 | 0.014 | ||
| GJB3 | gap junction protein, beta 3, 31kDa | 0.013 | ||
| BRAP | BRCA1 associated protein | 0.013 | ||
| TRIM35 | tripartite motif containing 35 | 0.013 | ||
| GOLGA2 | golgin A2 | 0.013 | ||
| LAD1 | ladinin 1 | 0.012 | ||
| IFNA10 | interferon, alpha 10 | 0.012 | Human | |
| TRIM52 | tripartite motif containing 52 | 0.012 | ||
| LY6E | lymphocyte antigen 6 complex, locus E | 0.012 | ||
| SHISA5 | shisa homolog 5 (Xenopus laevis) | 0.012 | ||
| RNF31 | ring finger protein 31 | 0.012 | ||
| RNF11 | ring finger protein 11 | 0.012 | ||
| ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0.012 | ||
| IFNA4 | interferon, alpha 4 | 0.011 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.011 | ||
| VTI1B | vesicle transport through interaction with t-SNAREs homolog 1B (yeast) | 0.011 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.011 | ||
| IFI35 | interferon-induced protein 35 | 0.011 | ||
| BCR | breakpoint cluster region | 0.011 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.011 | ||
| FBF1 | Fas (TNFRSF6) binding factor 1 | 0.011 | ||
| MCOLN1 | mucolipin 1 | 0.011 | ||
| JAG1 | jagged 1 | 0.011 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.011 | ||
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.011 | ||
| MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.011 | ||
| CRP | C-reactive protein, pentraxin-related | 0.011 | Human | |
| COL17A1 | collagen, type XVII, alpha 1 | 0.011 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.011 | ||
| IFNA17 | interferon, alpha 17 | 0.010 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.010 | ||
| IFI6 | interferon, alpha-inducible protein 6 | 0.010 | ||
| WFDC2 | WAP four-disulfide core domain 2 | 0.010 | ||
| RNF41 | ring finger protein 41 | 0.010 |